Rtw Investments as of Dec. 31, 2023
Portfolio Holdings for Rtw Investments
Rtw Investments holds 64 positions in its portfolio as reported in the December 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Rocket Pharmaceuticals (RCKT) | 8.3 | $530M | 18M | 29.97 | |
Immunocore Hldgs Ads (IMCR) | 6.5 | $417M | 6.1M | 68.32 | |
Mirati Therapeutics | 6.2 | $398M | 6.8M | 58.75 | |
Axsome Therapeutics (AXSM) | 5.6 | $357M | 4.5M | 79.59 | |
ACADIA Pharmaceuticals (ACAD) | 5.5 | $352M | 11M | 31.31 | |
Ultragenyx Pharmaceutical (RARE) | 5.1 | $329M | 6.9M | 47.82 | |
Alnylam Pharmaceuticals (ALNY) | 4.9 | $314M | 1.6M | 191.41 | |
Argenx Se Sponsored Adr (ARGX) | 4.0 | $254M | 667k | 380.43 | |
Bruker Corporation (BRKR) | 3.8 | $246M | 3.3M | 73.48 | |
Cytokinetics Com New (CYTK) | 3.3 | $211M | 2.5M | 83.49 | |
Ptc Therapeutics I (PTCT) | 3.2 | $205M | 7.4M | 27.56 | |
Madrigal Pharmaceuticals (MDGL) | 2.9 | $189M | 815k | 231.38 | |
Arvinas Ord (ARVN) | 2.7 | $173M | 4.2M | 41.16 | |
Masimo Corporation (MASI) | 2.7 | $171M | 1.5M | 117.21 | |
Penumbra (PEN) | 2.6 | $167M | 663k | 251.54 | |
Natera (NTRA) | 2.5 | $162M | 2.6M | 62.64 | |
Celldex Therapeutics Com New (CLDX) | 2.1 | $137M | 3.5M | 39.66 | |
Protagonist Therapeutics (PTGX) | 1.9 | $122M | 5.3M | 22.93 | |
Cargo Therapeutics (CRGX) | 1.9 | $120M | 5.2M | 23.15 | |
Vericel (VCEL) | 1.8 | $114M | 3.2M | 35.61 | |
Sage Therapeutics (SAGE) | 1.8 | $113M | 5.2M | 21.67 | |
Alkermes SHS (ALKS) | 1.7 | $108M | 3.9M | 27.74 | |
Avadel Pharmaceuticals Sponsored Adr | 1.5 | $98M | 6.9M | 14.12 | |
10x Genomics Cl A Com (TXG) | 1.4 | $87M | 1.5M | 55.96 | |
Akero Therapeutics (AKRO) | 1.3 | $84M | 3.6M | 23.35 | |
Merus N V (MRUS) | 1.0 | $65M | 2.4M | 27.50 | |
Establishment Labs Holdings Ord (ESTA) | 1.0 | $65M | 2.5M | 25.89 | |
Tarsus Pharmaceuticals (TARS) | 1.0 | $64M | 3.2M | 20.25 | |
89bio (ETNB) | 1.0 | $62M | 5.6M | 11.17 | |
Avidity Biosciences Ord (RNA) | 0.9 | $61M | 6.7M | 9.05 | |
Apogee Therapeutics (APGE) | 0.9 | $60M | 2.1M | 27.94 | |
Insmed Com Par $.01 (INSM) | 0.9 | $58M | 1.9M | 30.99 | |
Health Sciences Acq Corp 2 (OBIO) | 0.8 | $51M | 5.6M | 9.13 | |
Spyre Therapeutics Com New (SYRE) | 0.8 | $48M | 2.2M | 21.52 | |
Fulcrum Therapeutics (FULC) | 0.6 | $37M | 5.5M | 6.75 | |
Taysha Gene Therapies Com Shs (TSHA) | 0.5 | $30M | 17M | 1.77 | |
Danaher Corporation (DHR) | 0.4 | $27M | 119k | 231.34 | |
Thermo Fisher Scientific (TMO) | 0.4 | $27M | 50k | 530.79 | |
Urogen Pharma (URGN) | 0.4 | $26M | 1.7M | 15.00 | |
RadNet (RDNT) | 0.4 | $23M | 664k | 34.77 | |
Springworks Therapeutics (SWTX) | 0.4 | $23M | 625k | 36.50 | |
Stoke Therapeutics (STOK) | 0.3 | $22M | 4.1M | 5.26 | |
Tango Therapeutics (TNGX) | 0.3 | $20M | 2.0M | 9.90 | |
Gh Research Ordinary Shares (GHRS) | 0.3 | $19M | 3.3M | 5.80 | |
Roivant Sciences SHS (ROIV) | 0.3 | $16M | 1.5M | 11.23 | |
Immatics SHS (IMTX) | 0.2 | $16M | 1.5M | 10.53 | |
Essa Pharma Com New (EPIX) | 0.2 | $15M | 2.3M | 6.60 | |
Guardant Health (GH) | 0.2 | $13M | 493k | 27.05 | |
Miragen Therapeutics (VRDN) | 0.2 | $13M | 606k | 21.78 | |
Allurion Technologies Com Shs (ALUR) | 0.2 | $13M | 3.5M | 3.74 | |
Shockwave Med | 0.2 | $12M | 65k | 190.56 | |
Tourmaline Bio (TRML) | 0.2 | $10M | 399k | 26.18 | |
Adicet Bio (ACET) | 0.1 | $7.8M | 4.1M | 1.89 | |
Acelyrin (SLRN) | 0.1 | $7.3M | 978k | 7.46 | |
Immunic (IMUX) | 0.1 | $6.5M | 4.3M | 1.50 | |
Cutera (CUTR) | 0.1 | $6.4M | 1.8M | 3.52 | |
SAB Biotherapeutics | 0.1 | $6.3M | 9.2M | 0.69 | |
Milestone Pharmaceuticals (MIST) | 0.1 | $5.4M | 3.3M | 1.67 | |
Exagen (XGN) | 0.0 | $3.0M | 1.5M | 1.99 | |
Apyx Medical Corporation (APYX) | 0.0 | $2.7M | 1.0M | 2.62 | |
Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.0 | $1.4M | 128k | 10.90 | |
Sight Sciences (SGHT) | 0.0 | $850k | 165k | 5.16 | |
Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $172k | 350k | 0.49 | |
Sientra (SIENQ) | 0.0 | $49k | 81k | 0.61 |